Deal in question

Discussion in 'Celgene' started by anonymous, Feb 28, 2019 at 4:05 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    You do realize that stock price is not just based upon how you feel about the company? Lol, idiot. The financials of Celgene have not changed significantly from pre-offer, and pre-offer the market was aware that the stock price undervalued the revenues. At $70/share any company with the means to make a deal for Celgene would do so, including those with no synergies to be gained. Look at the spreadsheets it’s a no brainer... you will NEVER see Celgene stock drop below $70
     

  2. anonymous

    anonymous Guest

    Celgene stock was $59.21 on Decemeber 24, 2018. Pretty sure that is below $70.

    Boom, roasted!
     
  3. anonymous

    anonymous Guest

    Told you so. How much money did Wellington and Starboard make by shorting CELG and then buying after the artificial false drop? Good luck to all who want to stay or leave. I hope your future is what you want.
     
  4. anonymous

    anonymous Guest

    Celgene’s goose is cooked.

    Once Caforio gets control he is going to slash and burn Celgene’s work force like a one man wrecking crew to pay for this expensive acquisition.

    Get ready for massive layoffs after April.
     
  5. anonymous

    anonymous Guest

    He probably meant for a period long enough to be due to reason. The stock dipped for a couple weeks due to market overreaction and did not account for Celgene revenue.. which is exactly why they popped back to $80 after a week
     
  6. anonymous

    anonymous Guest

    We are literally praying to be laid off. Anyone that wants to stay at BMS likely is a Novartis transplant.
     
  7. anonymous

    anonymous Guest

    Seriously? They popped back to $80 a week later because BMS announced the deal a week later.